Stay up to date with the most recent announcements from the media

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Lifesciences

Times of India

Aug 7, 2022

Eyestem raises Series A round from Biological E, Alkem and others

Eyestem, a Bengaluru-based cell therapy company, has raised $6.4 million (Rs 51 Crore) in a Series A round led by three pharma majors - Biological E. Limited (BE), Alkem, NATCO and Anurag and Karan Bagaria, promoters of Kemwell Biopharma. Existing investors Endiya Partners and Kotak Private Equity also participated in this round

FinTech

Inc42

Jul 27, 2022

Equity Management Startup Qapita Acquires ESOP Direct To Expand In India And Southeast Asia

With this acquisition, ESOP Direct and Qapita, which create and manage ESOPs of private companies, has become a combined entity that can manage over $12 Bn worth ESOPs

Entrepreneur India

Jul 12, 2022

The Distinctive Investor

The investment philosophy at Endiya Partners has always been distinctive. The company invests across the SaaS, deep tech, financial services and healthcare sectors

Enterprise Tech

The Print

Jul 8, 2022

Scrut Automation launches Trust Vault, an integrated offering on its GRC platform

Scrut Automation, APAC’s leading information security (infosec) compliance automation platform, launched a new product called Trust Vault as an integrated offering to its smart GRC platform.

No items found.

News

Eyestem raises Series A round from Biological E, Alkem and others

Equity Management Startup Qapita Acquires ESOP Direct To Expand In India And Southeast Asia

The Distinctive Investor

Scrut Automation launches Trust Vault, an integrated offering on its GRC platform